BTZ-043

DB17737InvestigationalSmall molecule

BTZ-043: Overview.

Chemical structure of BTZ-043
Formula / weight
C17H16F3N3O5S · 431.39 g/mol (avg)
Also known as
2-((2s)-2-methyl-1,4-dioxa-8-azaspiro(4.5)decan-8-yl)-8-nitro-6-trifluoromethyl-4h-1,3-benzothiazin-4-one · 4h-1,3-benzothiazin-4-one, 2-((2s)-2-methyl-1,4-dioxa-8-azaspiro(4.5)dec-8-yl)-8-nitro-6-(trifluoromethyl)-
Code names
BTZ-043 · BTZ-10526043 · BZT043

Resolves to

Compound
UNIIG55ZH52P57CAS1161233-85-7ChEMBLCHEMBL1822872
Structure
InChIKeyGTUIRORNXIOHQR-VIFPVBQESA-NSMILESC[C@H]1COC2(CCN(CC2)C2=NC(=O)C3=CC(=CC(=C3S2)[N+]([O-])=O)C(F)(F)F)O1

What you can answer from here — as of May 04, 2023

8Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of BTZ-043, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In